Halo U: Intro To Aura And BMI 101
This is our first virtual course to demonstrate the easy usability of performing high throughput, low volume subvisible particle analysis…
Read MoreDon’t Let Aggregation Lead to Ruination: Early Detection Saves Lives
Do you currently chug along check boxing regulatory mandates described by USP? If so, you may be putting patients, and…
Read MoreBITC 2021 Symposium: High Throughput Low Volume Subvisible Particle Particle Sizing and ID for All Biologics
In this webinar, we present at the virtual Biomolecular Interaction Technologies Center (BITC) symposium demonstrating the expansive capabilities of the…
Read MoreProtein Or Not? Advanced Aggregate and Particle Analysis with Aura
In protein-based formulations, distinguishing aggregated API from other particle types is important for understanding the root cause of instability. Until…
Read MoreCell Line Development: Identifying Stable Biologic Candidates
Cell line development (CLD) is a critical aspect of the drug discovery process, and nowhere is this more apparent than…
Read MoreCharacterization of Protein Aggregates and Extrinsic Particles from Cell Line Development Through Release
Aura PTx is a complete protein therapeutic stability solution that enables characterization of subvisible particle aggregates from developability assessment through…
Read MoreCharacterize and Identify Subvisible Protein and Polysorbate Aggregates in Protein Therapeutics
Polysorbates 20 and 80 are excipients used in >70% of marketed parenteral biological drugs to improve product stability and shelf…
Read MoreEnsuring Safety to Achieve Rapid Release with Aura
Presented in-person at the 3rd annual Cell Therapy Analytical Development Summit in Boston, MA, CSO and co-founder Bernardo Cordovez, Ph.D.…
Read MoreFinding the Needle in a Haystack: Rapid Assays to Detect Degraded Polysorbate and Other Problems Lurking in your Formulation
Polysorbates 20 and 80 are excipients used in >70% of marketed parenteral biological drugs to improve product stability and shelf…
Read MoreFrom Cell Line to Final Formulation: Characterizing mAb Stability Throughout the Development Pathway
Antibody-producing Chinese hamster ovary (CHO) cell lines have been long used to produce antibodies without aggregation in mind. Aura+® is…
Read More
